Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
Colorado State University
AIDS Malignancy Consortium
Zagazig University
University Health Network, Toronto
Essen Biotech
Brigham and Women's Hospital
St. Jude Children's Research Hospital
Institut Bergonié
Duke University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Adela, Inc
M.D. Anderson Cancer Center
ITM Solucin GmbH
University of Salamanca
AC Camargo Cancer Center
National Cancer Institute (NCI)
University Health Network, Toronto
St. Jude Children's Research Hospital
Incyte Corporation
Immunitas Therapeutics
M.D. Anderson Cancer Center
Young Adult Survivors United
IRCCS San Raffaele
Cook Group Incorporated
Arab American University (Palestine)
National Cancer Institute (NCI)
Washington University School of Medicine
Incyte Corporation
AIDS Malignancy Consortium
Trishula Therapeutics, Inc.
Institut Bergonié
Tempus AI